Joseph Edelman, 10% Owner at VYNE Therapeutics Inc. (VYNE), sold 1,000,000 shares at $3.67 ($3.7M) on 2021-05-06, disclosed to the SEC on 2021-05-07.
Open-market sale of $3.7M VYNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |